Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26105025 | 0.95 | LMNA (0.43) | LMNABLMFFAR4FFAR1NFKB1 | |
| SCHEMBL10711383 | 0.93 | LMNA (0.56) | LMNABLMFFAR4FFAR1NFKB1 | |
| SCHEMBL8526279 | 0.92 | FFAR4 (0.47) | LMNAFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL28044993 | 0.92 | FFAR4 (0.47) | LMNAFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL8896229 | 0.92 | FFAR4 (0.47) | LMNAFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL17526403 | 0.90 | LMNA (0.43) | LMNABLMFFAR4FFAR1NFKB1 | |
| SCHEMBL7404028 | 0.90 | LMNA (0.43) | LMNABLMFFAR4FFAR1NFKB1 | |
| SCHEMBL17526442 | 0.90 | LMNA (0.43) | LMNABLMFFAR4FFAR1NFKB1 | |
| SCHEMBL30787147 | 0.89 | FFAR4 (0.44) | LMNAFFAR4FFAR1NFKB1GPR84 | |
| SCHEMBL14462728 | 0.89 | LMNA (0.53) | LMNABLMFFAR4FFAR1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| CN-101613427-B | Method for preparing polyisobutylene with high reaction activity | UNIV BEIJING CHEMICAL | 2011-04-20 | — | — | CN | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| CN-101613427-A | The preparation method of high-activity polyisobutylene | UNIV BEIJING CHEMICAL | 2009-12-30 | — | — | CN | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| CN-119744164-A | Odor and colorant stable compositions | 西姆莱斯股份公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119604270-A | Comprising an antimicrobial agent accelerator composition | 西姆莱斯股份公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250000088-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-01-02 | — | — | US | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| EP-4424164-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-09-04 | — | — | EP | disclosed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| EP-0804397-A1 | OXYGENATES AND PROCESSES FOR THEIR MANUFACTURE | EXXON CHEMICAL PATENTS INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996022264-A1 | OXYGENATES AND PROCESSES FOR THEIR MANUFACTURE | EXXON CHEMICAL PATENTS INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| US-4094892-A | CLAISEN REARRANGEMENT | HOFFMANN-LA ROCHE INC. (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | LMNA 3717/4885BLM 1093/4885FFAR4 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.